BORTEZOMIB | N209191 | HOSPIRA INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Gland Pharma Limited FDA-2021-P-0339 Gland Pharma Limited filed this citizen petition on March 22, 2021, requesting that the FDA determine whether Bortezomib for Injection in 1 mg/vial and 2.5 mg/vial strengths (NDA 209191), held by Hospira Inc., was voluntarily withdrawn from sale for reasons of safety or effectiveness, as required un | 505(q) | 2021-04-13 | Withdrawn | Gland Pharma Limited |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.